Mikalai Yatskou

Dr. Mikalai Yatskou

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
THTatsiana Mikalaevna Halavach
Tatsiana Mikalaevna Halavach
VKVladimir P. Kurchenko
Vladimir P. Kurchenko
ETEkaterina I. Tarun
Ekaterina I. Tarun
NDNatalia V. Dudchik
Natalia V. Dudchik
MYMikalai Yatskou
Mikalai Yatskou
Natasa Poklar UlrihNatasa Poklar Ulrih
Natasa Poklar Ulrih
Dairy protein hydrolysates possess a broad spectrum of bioactivity and hypoallergenic properties, as well as pronounced bitter taste. The bitterness is reduced by complexing the proteolysis products with cyclodextrins (CDs), and it is also important to study the bioactivity of the peptides in inclusion complexes. Hydrolysates of whey and colostrum proteins with extensive hydrolysis degree and their complexes with β/γ-CD were obtained in the present study, and comprehensive comparative analysis of the experimental samples was performed. The interaction of CD with peptides was confirmed via different methods. Bioactivity of the initial hydrolysates and their complexes were evaluated. Antioxidant activity (AOA) was determined by fluorescence reduction of fluorescein in the Fenton system. Antigenic properties were studied by competitive enzyme immunoassay. Antimutagenic effect was estimated in the Ames test. According to the experimental data, a 2.17/2.78-fold and 1.45/2.14-fold increase in the AOA was found in the β/γ-CD interaction with whey and colostrum hydrolysates, respectively. A 5.6/5.3-fold decrease in the antigenicity of whey peptides in complex with β/γ-CD was detected, while the antimutagenic effect in the host–guest systems was comparable to the initial hydrolysates. Thus, bioactive CD complexes with dairy peptides were obtained. Complexes are applicable as a component of specialized foods (sports, diet).

21 May 2020 in Journal of Applied Spectroscopy
Verified
Journal Article
Closed access
PDF file
MYMikalai Yatskou
Mikalai Yatskou
VSV. V. Skakun
V. V. Skakun
VAV. V. Apanasovich
V. V. Apanasovich

11 September 2020 in Journal of Applied Spectroscopy
Verified
Journal Article
Closed access
PDF file
MYMikalai Yatskou
Mikalai Yatskou
VSVictor Skakun
Victor Skakun
LNLaura Nederveen-Schippers
Laura Nederveen-Schippers
Arjan KortholtArjan Kortholt
Arjan Kortholt
VAV. V. Apanasovich
V. V. Apanasovich

16 July 2021 in Journal of Applied Spectroscopy
Verified
Journal Article
Closed access
PDF file
MYMikalai Yatskou
Mikalai Yatskou
VAV. V. Apanasovich
V. V. Apanasovich

25 April 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
Alexander N ChernovAlexander N Chernov
Alexander N Chernov
SSSofia S. Skliar
Sofia S. Skliar
MYMikalai Yatskou
Mikalai Yatskou
VSVictor Skakun
Victor Skakun
SPSarng Pyurveev
Sarng Pyurveev
SISergey D. Ivanov
Sergey D. Ivanov
Background: Glioblastoma multiforme (GBM) is a very malignant brain tumor. GBM exhibits cellular and molecular heterogeneity that can be exploited to improve patient outcomes by individually tailoring chemotherapy regimens. Objective: Our objective was to develop a predictive model of the life expectancy of GBM patients using data on tumor cells’ sensitivity to chemotherapy drugs, as well as the levels of blood cells and proteins forming the tumor microenvironment. Methods: The investigation included 31 GBM patients from the Almazov Medical Research Centre (Saint Petersburg, Russia). The cytotoxic effects of chemotherapy drugs on GBM cells were studied by an MTT test using a 50% inhibitory concentration (IC50). We analyzed the data with life expectancy by a one-way ANOVA, principal component analysis (PCA), ROC, and Kaplan–Meier survival tests using GraphPad Prism and Statistica 10 software. Results: We determined in vitro the IC50 of six chemotherapy drugs for GBM and 32 clinical and biochemical blood indicators for these patients. This model includes an assessment of only three parameters: IC50 of tumor cells to carboplatin (CARB) higher than 4.115 μg/mL, as well as levels of band neutrophils (NEUT-B) below 2.5% and total protein (TP) above 64.5 g/L in the blood analysis, which allows predicting with 83.3% probability (sensitivity) the life expectancy of patients for 15 months or more. In opposite, a change in these parameters—CARB above 4115 μg/mL, NEUT-B below 2.5%, and TP above 64.5 g/L—predict with 83.3% probability (specificity) no survival rate of GBM patients for more than 15 months. The relative risk for CARB was 6.41 (95 CI: 4.37–8.47, p = 0.01); for NEUT-B, the RR was 0.40 (95 CI: 0.26–0.87, p = 0.09); and for TP, it was 2.88 (95 CI: 1.57–4.19, p = 0.09). Overall, the model predicted the risk of developing a positive event (an outcome with a life expectancy more than 10 months) eight times (95 CI 6.34–9.66, p < 0.01). Cross k-means validation on three clusters (n = 10) of the model showed that its average accuracy (sensitivity and specificity) for cluster 1 was 74.98%; for cluster 2, it was 66.7%; and for cluster 3, it was 60.0%. At the same time, the differences between clusters 1, 2, and 3 were not significant. The results of the Sobel test show that there are no interactions between the components of the model, and each component is an independent factor influencing the event (life expectancy, survival) of GBM patients. Conclusions: A simple predictive model for GBM patients’ life expectancy has been developed using statistical analysis methods.

15 December 2023
Verified
Book Chapter
Open access
PDF file
MYMikalai Yatskou
Mikalai Yatskou
ESElizabeth V. Smolyakova
Elizabeth V. Smolyakova
VSVictor V. Skakun
Victor V. Skakun
VGVasily V. Grinev
Vasily V. Grinev
The paper presents an algorithm for simulation modelling of nucleotide variations in the genomic DNA molecule. To identify single nucleotide genetic polymorphisms, it is proposed to use machine learning methods trained on simulated data. A comparative analysis of the most effective classical and machine learning algorithms for identifying single nucleotide polymorphisms was performed on simulated data. The most optimal method for identifying single nucleotide genetic polymorphisms in DNA molecules at various experimental noise levels is the machine learning algorithm CART.